The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gognieva D.G.

Sechenov First Moscow State Medical University, Moscow, Russia

Shchekochikhin D.Iu.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova;
Moskovskiĭ gosudarstvennyĭ universitet im. M.V. Lomonosova

Shilova A.S.

N.I. Pirogov Moscow Municipal Hospital №1, Moscow, 119049, Russia;
N.I. Pirogov Russian National Research Medical University under the Ministry of Health of the Russia, 117997, Moscow, Russia

Bogdanova A.A.

Pirogov Municipal Clinical Hospital №1 of Moscow Department of Health, Moscow, Russia

Giliarov M.Yu.

I.M. Sechenov First Moscow State Medical University under the Ministry of Health of the Russia, 119991, Moscow, Russia;
N.I. Pirogov Moscow Municipal Hospital №1, Moscow, 119049, Russia

Svet A.V.

GOU VPO Pervyĭ MGMU im. I.M. Sechenova Minzdrava Rossii

Syrkina E.A.

Chair of Preventive and Emergency Cardiology, Research Center of Mental Health RAS, Moscow, Russia

Kopylov F.Iu.

Pervyĭ MGMU im. I.M. Sechenova, kafedra profilakticheskoĭ i neotlozhnoĭ kardiologii FPPOV, Moskva

Syrkin A.L.

Sechenov First Moscow State Medical University

Transient pulmonary hypertension as a manifestation of hyperthyroidism (in Russian only)

Authors:

Gognieva D.G., Shchekochikhin D.Iu., Shilova A.S., Bogdanova A.A., Giliarov M.Yu., Svet A.V., Syrkina E.A., Kopylov F.Iu., Syrkin A.L.

More about the authors

Read: 5381 times


To cite this article:

Gognieva DG, Shchekochikhin DIu, Shilova AS, et al. Transient pulmonary hypertension as a manifestation of hyperthyroidism (in Russian only). Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(4):340‑343. (In Russ., In Engl.)
https://doi.org/10.17116/kardio201912041340

Recommended articles:
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Search for risk factors for slowed intra-atrial conduction in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):111-116
A clinical case of ineffective treatment of infe­ction caused by Myco­plasma geni­talium. Russian Journal of Clinical Dermatology and Vene­reology. 2026;(1):31-35

References:

  1. Yue WS, Chong BH, Zhang XH, et al. Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure. Clin Endocrinol. 2011;74(5):636-643. https://doi.org/10.1111/j.13652265.2011.03981.x
  2. Siu CW, Yeung CY, Lau CP, et al. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart. 2007;93(4):483-487. https://doi.org/10.1136/hrt.2006.100628
  3. Marvisi M, Brianti M, Marani G, et al. Hyperthyroidism and pulmonary hypertension. Respir Med. 2002;96(4):215-220.
  4. Armigliato M, Paolini R, Aggio S, et al. Hyperthyroidism as a cause of pulmonary arterial hypertension: a prospective study. Angiology. 2006;57(5):600-606. https://doi.org/10.1177/0003319706293131
  5. Li JH, Safford RE, Aduen JF, et al. Pulmonary hypertension and thyroid disease. Chest. 2007;132(3):793-797. https://doi.org/10.1378/chest.07-0366
  6. Badesch DB, Raskob GE, Elliott CG, et al. Pultamonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137:376-387. https://doi.org/10.1378/chest.09-1140
  7. Vallabhajosula S, Radhi S, Cevik C, et al. Hyperthyroidism and pulmonary hypertension: an important association. Am J Med Sci. 2011;342:507-512. https://doi.org/10.1097/MAJ.0b013e31821790f4
  8. Shimazaki M, Mitsuhashi T, Hasegawa K. Idiopathic pulmonary hypertension associated with hyperthyroidism—an autopsy case. Nihon Rinsho. 1980;38(3):1783-1786.
  9. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725-1735. https://doi.org/10.1161/CIRCULATIONAHA.106.678326
  10. Aird WC. Endothelial cell heterogeneity. Crit Care Med. 2003;31:S221-S230. https://doi.org/10.1097/01.CCM.0000057847.32590.C1
  11. Smit JW, Eustatia-Rutten CF, Corssmit EP, et al. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab. 2005;90:6041-6047. https://doi.org/10.1210/jc.2005-0620
  12. Leung CC, Moondra V, Catherwood E, et al. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol. 2010;106:284-286. https://doi.org/10.1016/j.amjcard.2010.02.039
  13. Thomas MR, McGregor AM, Jewitt DE. Left ventricle filling abnormalities prior to and following treatment of thyrotoxicosis—is diastolic dysfunction implicated in thyrotoxic cardiomyopathy? Eur Heart J. 1993;14:662-668.
  14. Li JH, Stafford RE, Aduen JF, et al. Pulmonary hypertension and thyroid disease. Chest. 2007;132:793-797. https://doi.org/10.1378/chest.07-0366
  15. Papaioannou AI, Zakynthinos E, Kostikas K, et al. Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. BMC Pulm Med. 2009;9:18. https://doi.org/10.1186/1471-2466-9-18
  16. Tuder RM, Yun HJ. Vascular endothelial growth factor of the lung: friend or foe. Curr Opin Pharmacol. 2008;8:255-260. https://doi.org/10.1016/j.coph.2008.03.003
  17. Davis PJ. Cytokines and growth factors and thyroid hormone. Curr Opin Endocrinol Diabetes Obes. 2008;5:428. https://doi.org/10.1097/MED.0b013e32830eba0e
  18. Chu CH, Lee JK, Keng HM, et al. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations. Exp Biol Med (Maywood). 2006;231:1040-1043. https://doi.org/10.17179/excli2017-275
  19. Steiner MK, Syrkina OL, Kolliputi N, et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009;104:236-244. https://doi.org/10.1161/CIRCRESAHA.108.182014
  20. Davis FB, Mousa SA, O’Connor L, et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res. 2004;94:1500-1506. https://doi.org/10.1161/01.RES.0000130784.90237.4a
  21. Fujita M, Shannon JM, Irvin CG, et al. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001;280:L39-L49. https://doi.org/10.1152/ajplung.2001.280.1.L39

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.